Headlands Technologies LLC Karuna Therapeutics, Inc. Transaction History

Headlands Technologies LLC

  • $920 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024
BUY
$161.01 - $317.85 $190,313 - $375,698
1,182 New
1,182 $374,000
Q2 2023

Aug 03, 2023
BUY
$176.32 - $240.22 $269,240 - $366,815
1,527 Added 1839.76%
1,610 $349,000
Q1 2023

May 01, 2023
BUY
$161.33 - $204.36 $13,390 - $16,961
83 New
83 $15,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email